Atlas Trials

Curcumin and EGCG Supplementation to Improve Serum BDNF and Mood Disturbance

Clinical trial NCT06531863 · RECRUITING

Trial details

NCT number
NCT06531863
Sponsor
Auburn University
Status
RECRUITING
Phase
Early Phase 1
Study type
INTERVENTIONAL
Mood Disturbance
Start date
2024-09-30
Primary completion
2025-05-01
Enrollment
64

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.